Cyteir Therapeutics
Stock Forecast, Prediction & Price Target
Cyteir Therapeutics Financial Estimates
Cyteir Therapeutics Revenue Estimates
Cyteir Therapeutics EBITDA Estimates
Cyteir Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2025 | |||
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | |||
Net Income
% change YoY
| $-20.82M N/A | $-41.64M -100.00% | $-43.95M -5.53% | Avg: $-23.49M Low: $-23.49M High: $-23.49M avg. 46.53% | |||
EBITDA
% change YoY
| $-20.59M N/A | $-42.25M -105.22% | $-48.17M -13.98% | Avg: $0 Low: $0 High: $0 avg. 100% | |||
EPS
% change YoY
| -$0.87 N/A | -$2.14 -145.97% | -$1.25 41.58% | Avg: -$0.67 Low: -$0.67 High: -$0.67 avg. 46.70% | |||
Operating Expenses
% change YoY
| $20.94M N/A | $42.25M 101.78% | $48.17M 13.98% | Avg: $0 Low: $0 High: $0 avg. -100% | |||
FAQ
What is Cyteir Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 46.53% in 2025-2025.
We have gathered data from N/A analysts. Their low estimate is -23.49M, average is -23.49M and high is -23.49M.
What is Cyteir Therapeutics stock revenue growth forecast?
We have gathered data from N/A analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Cyteir Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 46.70% in 2025-2025.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$0.67, average is -$0.67 and high is $-0.66.